Andere talen Aridis Pharmaceuticals, Inc.

Aandelen

ARDS

US0403341045

Beurs gesloten - OTC Markets Andere beurzen 21:12:26 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0615 ^USD	-6,78%		-16,33%	-12,27%

2023	Aridis Pharmaceuticals, Inc. rapporteert winstresultaten voor het derde kwartaal en de negen maanden afgesloten op 30 september 2023	CI
2023	Aridis Pharmaceuticals, Inc. Rapporteert winstresultaten voor het tweede kwartaal en de zes maanden afgesloten op 30 juni 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024	15/12
Aridis Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update	03/11
Certain Options of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023.	16-09-23
Certain Warrants of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023.	16-09-23
Certain Pre-Funded Warrant of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023.	16-09-23
Certain Common Stock of Aridis Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 16-SEP-2023.	16-09-23
Aridis Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-09-23
Aridis Pharmaceuticals : Termination of Material Agreement - Form 8-K	25-08-23
Aridis Pharmaceuticals, Inc. Announces Resignation as Chief Financial Officer	09-08-23
Aridis Pharmaceuticals Announces $2 Million Offering	02-08-23
CapitalGainsReport Penny Stock Bounce List: EPAZ, ARDS, FRTX, GNPX	24-07-23
Aridis Pharmaceuticals, Inc.(OTCPK:ARDS) dropped from S&P TMI Index	21-07-23
Aridis Pharmaceuticals : Accelaration/Increase of Financial Obligation - Form 8-K	21-07-23
Sector Update: Health Care Stocks Steady Premarket Tuesday	18-07-23
Aridis Pharmaceuticals, European Regulator Agree on Pneumonia Phase 3 Study Parameters; Shares Jump Premarket	18-07-23
Aridis Pharmaceuticals, Inc.(OTCPK:ARDS) dropped from NASDAQ Composite Index	18-07-23
Aridis Pharmaceuticals Reaches Agreement for Phase 3 Study of Pneumonia Treatment in Europe; Shares Jump After Hours	17-07-23
Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301	17-07-23
Aridis Receives Agreement from the European Medicines Agency on the Clinical Study Design and A Single Confirmatory Phase 3 Study of AR-301	17-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aridis Pharmaceuticals, Inc.

Aandelen

ARDS

US0403341045

Andere talen

Filters